Journal Article

New Pyrazolyl Thioureas Active against the Staphylococcus Genus

Cichero, Elena, Caviglia, Debora, Tasso, Bruno, Schito, Anna Maria, Penco, Susanna, Spallarossa, Andrea, Brullo, Chiara

2024

Overview

To meet the urgent need for new antibacterial molecules, a small library of pyrazolyl thioureas (PTUs) was designed, synthesized and tested against difficult-to-treat human pathogens. The prepared derivatives are characterized by a carboxyethyl functionality on C4 and different hydroxyalkyl chains on N1. Compounds 1a–o were first evaluated against a large panel of Gram-positive and Gram-negative pathogens. In particular, the majority of PTUs proved to be active against different species of the Staphylococcus genus, with MIC values ranging from 32 to 128 µg/mL on methicillin-resistant Staphylococcus strains, often responsible for severe pulmonary disease in cystic fibrosis patients. Time-killing experiments were also performed for the most active compounds, evidencing a bacteriostatic mechanism of action. For most active derivatives, cytotoxicity was evaluated in Vero cells, and at the tested concentrations and at the experimental exposure time of 24 h, none of the compounds analysed showed significant toxicity. In addition, favourable drug-like, pharmacokinetic and toxicity properties were predicted for all new synthesized derivatives. Overall, the collected data confirmed the PTU scaffold as a promising chemotype for the development of novel antibacterial agents active against Gram-positive multi-resistant strains frequently isolated from cystic fibrosis patients.

• Publisher: MDPI AG,MDPI
• Subject: antibacterial activity / Antibiotics / Bacterial infections / Cystic fibrosis / Cytotoxicity / Drug resistance / Gram-positive species / Infectious diseases / Pathogens / Pharmacokinetics / pyrazoles / pyrazolyl thiourea / Small libraries / Staphylococcus genus / Staphylococcus infections / Toxicity